Advanced Oncotherapy (AVO) – Holdings in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi   1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights     An acquisition or disposal of qualifying […]

Advanced Oncotherapy (AVO) – Update on Harley Street

Advanced Oncotherapy plc (AVO) notes that a number of shareholders have raised concerns that a planning application submitted by Howard de Walden Estates Limited for 141-143 Harley Street was withdrawn in January 2016 and that this will have an impact on the Company’s progress.  Howard de Walden Estates and Advanced Oncotherapy have confirmed that the […]

Advanced Oncotherapy (AVO) – Exercise of Warrants and issue of Shares

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 14,000 new ordinary shares of 1p in the Company at a price of 6 pence per New Share pursuant to the exercise of 14,000 warrants. Application has been made for the 14,000 Shares to be admitted […]

Advanced Oncotherapy (AVO) Proton Therapy Programme Progressing Well – IFA Magazine

Advanced Oncotherapy (AVO) was moving closer to success with its proton therapy for cancer treatment, updating the market on Tuesday of progress with its proton accelerator programme, dubbed ‘LIGHT’. The AIM-traded company said its proton source, which was being constructed by Pantechnik in Bayeux, France, had been fully assembled and was ready for initial testing […]

Sanjeev Pandya of Advanced Oncotherapy (AVO) interviewed by BRR Media

Sanjeev Pandya, Executive Vice President for Global Business Development for Advanced Oncotherapy (AVO) provides an update to shareholders on development progress of the Company’s novel proton accelerator. Sanjeev also introduces Michel Baelen, the recently appointed Global Head of Regulatory Affairs. Click the image to watch.    

Testing underway for UK proton beam cancer treatment – Daily Telegraph

By Tara Cunningham 28 MARCH 2016 • 7:03PM Aim-listed Advanced Oncotherapy (AVO) has begun testing its groundbreaking Light machine for the UK’s first proton beam therapy centre, in what is expected to be a cancer treatment milestone when it opens by the end of next year. Proton beam therapy uses protons to pinpoint tumours more […]

Daily Actions – UK Main & AIM markets 31032016

Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London AIM Market ST Rec. changed From To Banks & Investment Banks Arden Partners Sell Neutral Basic Resources   […]